Brief: JPMorgan Chase & Co's Long Position In Wuxi Biologics Increases To 6.27% - HKEX
March 20 (Reuters) -
* JPMORGAN CHASE & CO'S LONG POSITION IN WUXI BIOLOGICS
INCREASES
TO 6.27% ON MARCH 15 FROM 5.75% - HKEX
Further company coverage: 2269.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln